Effects of Docosahexaenoic Acid on Chemokine Expression in Human Conjunctival Fibroblasts

References

• Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Kumagai N, Satake Y, Shoji J, Nakagawa Y, et al. Japanese guideline for allergic conjunctival diseases. Allergol Int. 2011;60(2):191–203. doi:10.2332/allergolint.11-RAI-0335.
   PubMedGoogle Scholar
• Ennis M, Barrow SE, Blair IA. Prostaglandin and histamine release from stimulated rat peritoneal mast cells. Agents Actions. 1984;14:397–400.
   PubMedGoogle Scholar
• Proud D, Sweet J, Stein P, Settipane RA, Kagey-Sobotka A, Friedlaender MH, Lichtenstein LM. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol. 1990;85:896–905.
   PubMed Web of Science ®Google Scholar
• Deinema LA, Vingrys AJ, Wong CY, Jackson DC, Chinnery HR, Downie LE. A randomized, double-masked, placebo-controlled clinical trial of two forms of omega-3 supplements for treating dry eye disease. Ophthalmology. 2017;124:43–52.
   PubMed Web of Science ®Google Scholar
• Downie LE, Vingrys AJ. Oral omega-3 supplementation lowers intraocular pressure in normotensive adults. Transl Vis Sci Technol. 2018;7:1.
   PubMed Web of Science ®Google Scholar
• Downie LE, Keller PR. Nutrition and age-related macular degeneration: research evidence in practice. Optom Vis Sci. 2014;91:821–31.
   PubMed Web of Science ®Google Scholar
• Huang TH, Wang PW, Yang SC, Chou WL, Fang JY. Cosmetic and therapeutic applications of fish oil’s fatty acids on the skin. Mar Drugs. 2018;16(8):1–20.
   Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92–101.
   PubMed Web of Science ®Google Scholar
• Warstedt K, Furuhjelm C, Falth-Magnusson K, Fageras M, Duchen K. High levels of omega-3 fatty acids in milk from omega-3 fatty acid-supplemented mothers are related to less immunoglobulin E-associated disease in infancy. Acta Paediatr. 2016;105:1337–47.
   PubMed Web of Science ®Google Scholar
• Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol. 2003;112(6):1178–84. doi:10.1016/j.jaci.2003.09.009.
   PubMed Web of Science ®Google Scholar
• Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J. 2000;16:861–65.
   PubMed Web of Science ®Google Scholar
• Peat JK, Mihrshahi S, Kemp AS, Marks GB, Tovey ER, Webb K, Mellis CM, Leeder SR. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the childhood asthma prevention study. J Allergy Clin Immunol. 2004;114(4):807–13. doi:10.1016/j.jaci.2004.06.057.
   PubMed Web of Science ®Google Scholar
• Olsen SF, Osterdal ML, Salvig JD, Mortensen LM, Rytter D, Secher NJ, Henriksen TB. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial. Am J Clin Nutr. 2008;88(1):167–75. doi:10.1093/ajcn/88.1.167.
   PubMed Web of Science ®Google Scholar
• Hansen S, Strom M, Maslova E, Dahl R, Hoffmann HJ, Rytter D, Bech BH, Henriksen TB, Granstrom C, Halldorsson TI, et al. Fish oil supplementation during pregnancy and allergic respiratory disease in the adult offspring. J Allergy Clin Immunol. 2017;139(1):104–111 e104. doi:10.1016/j.jaci.2016.02.042.
   PubMed Web of Science ®Google Scholar
• Hirakata T, Lee HC, Ohba M, Saeki K, Okuno T, Murakami A, Matsuda A, Yokomizo T. Dietary omega-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating Th2 immune responses. Faseb J. 2019;33(3):3392–3403.
   PubMed Web of Science ®Google Scholar
• Fukagawa K, Okada N, Fujishima H, Nakajima T, Takano Y, Tanaka M, Dogru M, Satake Y, Tsubota K, Saito H. Corneal and conjunctival fibroblasts are major sources of eosinophil-recruiting chemokines. Allergol Int. 2009;58(4):499–508. doi:10.2332/allergolint.09-OA-0092.
   PubMedGoogle Scholar
• Chihara J, Yamada H, Takamura E, Yoshino K, Nakajima S. Possible presence of RANTES in tears of patients with allergic conjunctivitis. Int Arch Allergy Immunol. 1995;106(4):428. doi:10.1159/000236878.
   PubMed Web of Science ®Google Scholar
• Fukagawa K, Nakajima T, Tsubota K, Shimmura S, Saito H, Hirai K. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol. 1999;103(6):1220–21. doi:10.1016/s0091-6749(99)70206-x.
   PubMed Web of Science ®Google Scholar
• Shimizu E, Yazu H, Satake Y, Fukagawa K, Aketa N, Murat D, Okada N, Fujishima H. The effect of cytokine-stimulation and pharmacologic intervention on PGE2 production in primary human conjunctival and corneal cells. Ocul Immunol Inflamm. 2019;1–7. doi:10.1080/09273948.2019.1595669.
   PubMed Web of Science ®Google Scholar
• Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007;447:869–74.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002;196:1025–37.
   PubMed Web of Science ®Google Scholar
• Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005;115:2774–83.
   PubMed Web of Science ®Google Scholar
• Shimanaka Y, Kono N, Taketomi Y, Arita M, Okayama Y, Tanaka Y, Nishito Y, Mochizuki T, Kusuhara H, Adibekian A, et al. ＊Omega-3 fatty acid epoxides are autocrine mediators that control the magnitude of IgE-mediated mast cell activation. Nat Med. 2017;23(11):1287–97.
   PubMed Web of Science ®Google Scholar
• Laing KJ, Secombes CJ. Chemokines. Dev Comp Immunol. 2004;28:443–60.
   PubMed Web of Science ®Google Scholar
• Fukagawa K, Nakajima T, Saito H, Tsubota K, Shimmura S, Natori M, Hirai K. IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells. Int Arch Allergy Immunol. 2000;121:144–50.
   PubMed Web of Science ®Google Scholar
• Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Tiffany HL, Murphy PM, Yoshie O. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem. 1996;271:7725–30.
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Kato Y, Atsuta J, Terada A, Iguchi K, Kamiya H, Yamada H, Nakajima T, Miyamasu M, Hirai K. Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines. J Allergy Clin Immunol. 2000;105:126–33.
   PubMed Web of Science ®Google Scholar